[HTML][HTML] CRISPR/Cas13: A potential therapeutic option of COVID-19

M Lotfi, N Rezaei - Biomedicine & Pharmacotherapy, 2020 - Elsevier
The novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) can be considered as the most important current global issue, as it has caused the novel …

CRISPR/Cas9: the Jedi against the dark empire of diseases

S Khan, MS Mahmood, SU Rahman, H Zafar… - Journal of biomedical …, 2018 - Springer
Abstract Advances in Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR
associated system (CRISPR/Cas9) has dramatically reshaped our ability to edit genomes …

Antiviral therapies: advances and perspectives

BC Gonçalves, MG Lopes Barbosa… - Fundamental & …, 2021 - Wiley Online Library
Viral infections cause high morbidity and mortality, threaten public health, and impose a
socioeconomic burden. We have seen the recent emergence of SARS‐CoV‐2 (Severe …

CRISPR/Cas system: a potential technology for the prevention and control of COVID-19 and emerging infectious diseases

R Ding, J Long, M Yuan, Y Jin, H Yang… - Frontiers in cellular …, 2021 - frontiersin.org
The continued global pandemic of coronavirus disease 2019 (COVID-19) poses a serious
threat to global public health and social stability and it has become a serious global public …

A broad application of CRISPR Cas9 in infectious, inflammatory and neurodegenerative diseases

K Pahan - Journal of Neuroimmune Pharmacology, 2019 - Springer
Being the most important immune-responsive cell type of the CNS, microglia always glorify
the so-called crossroad of Neurology, Immunology and Pharmacology. As microglial …

The use of CRISPR/Cas9 as a tool to study human infectious viruses

H Lin, G Li, X Peng, A Deng, L Ye, L Shi… - Frontiers in Cellular …, 2021 - frontiersin.org
Clustered regularly interspaced short palindromic repeats (CRISPR) systems are a set of
versatile gene-editing toolkit that perform diverse revolutionary functions in various fields of …

CRISPR/Cas9 in cancer therapy: A review with a special focus on tumor angiogenesis

K naidu gopal Hariprabu, M Sathya… - International Journal of …, 2021 - Elsevier
Tumor angiogenesis is a critical target for cancer treatment and its inhibition has become a
common anticancer approach following chemotherapy. However, due to the simultaneous …

CRISPR: the multidrug resistance endgame?

A Shukla, N Jani, M Polra, A Kamath, D Patel - Molecular Biotechnology, 2021 - Springer
The flexibility of microbes to undergo or adapt to the changes in their physiology and
genotypical traits has enabled the microbes acquiring resistance to latest or recently …

[HTML][HTML] The impact of CRISPR-Cas system on antiviral therapy

H Bayat, F Naderi, AH Khan… - Advanced …, 2018 - ncbi.nlm.nih.gov
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein
nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II …

CRISPR-Cas9, a promising therapeutic tool for cancer therapy: A review

F Akram, I Ul Haq, Z Ahmed, H Khan… - Protein and peptide …, 2020 - ingentaconnect.com
Cancer is one of the most leading causes of mortality all over the world and remains a
foremost social and economic burden. Mutations in the genome of individuals are taking …